Rift valley fever medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Changes made per Mahshid's request |
||
Line 10: | Line 10: | ||
[[Category:Needs overview]] | [[Category:Needs overview]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Viral diseases]] | [[Category:Viral diseases]] | ||
[[Category:Bunyaviruses]] | [[Category:Bunyaviruses]] |
Revision as of 18:39, 18 September 2017
Rift valley fever Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Rift valley fever medical therapy On the Web |
American Roentgen Ray Society Images of Rift valley fever medical therapy |
Risk calculators and risk factors for Rift valley fever medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Medical Therapy
There is no established course of treatment for patients infected with RVF virus.
Pharmacotherapy
Studies in monkeys and other animals have shown promise for ribavirin, an antiviral drug, for future use in humans. Additional studies suggest that interferon, immune modulators, and convalescent-phase plasma may also help in the treatment of patients with RVF.